biotech

US To Acquire Anthrax Drug From Cangene

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on July 28, 2006

2004 Complete Guide to Biological Weapons and Terrorism, Anthrax, Smallpox, Monkeypox, Ricin, Botulism, Brucellosis, Toxins, Plague, Q Fever, Tularemia, ... WMD, First Responder Two CD-ROM Set)
In June the US government has agreed to purchase 20,000 doses of ABthraxâ„¢ from Human Genome Sciences. But the stockpiling of drugs against inhalational anthrax, a potential bioweapon causing an acute infectious disease resulting from inhaling spores of Bacillus anthracis, is not yet over. Still under the Project BioShield Act of 2004, the U.S. Department of Health and Human Services will acquire an additional 10,000 doses of anthrax immune globulin (AIG) for $143 million, this time from Cangene.

More information about AIG and the supply contract from Cangene's press release.


Permalink: US To Acquire Anthrax Drug From Cangene

Tags: anthrax  bioweapon  biotech  cangene  acquire  acquire+anthrax  anthrax+drug  stem+cells 

Vote for US To Acquire Anthrax Drug From Cangene:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells